Benyo D F, Little-Ihrig L, Zeleznik A J
Department of Physiology, University of Pittsburgh School of Medicine, Pennsylvania 15261.
Endocrinology. 1993 Aug;133(2):699-704. doi: 10.1210/endo.133.2.8344208.
In nonfertile cycles, the absolute steroidogenic capacity of the primate corpus luteum, as reflected in the expression of messenger RNA (mRNA) for the progesterone biosynthetic enzymes cytochrome P450 cholesterol side-chain cleavage (P450SCC) and 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD), progressively declines until luteal regression. Despite this progressive loss in luteal cell function, the elaboration of CG by the implanted blastocyst is able to prolong the functional lifespan of the corpus luteum. It was the purpose of this study to investigate the relationship between aging of the primate corpus luteum and the cellular mechanisms by which the decline in luteal cell function is arrested by CG. Corpora lutea were obtained from cynomolgus monkeys on days 11 or 16 of the luteal phase after a 7-day treatment period with increasing doses of human CG (hCG) given intramuscularly beginning on days 5 or 10. Corpora lutea were also obtained from control animals on days 5, 10, 11, and 16 of the luteal phase. Human CG treatment significantly (P < 0.05) elevated both serum progesterone and estradiol levels throughout the treatment period; however, progesterone production in animals treated with hCG late in the luteal phase (days 10-16) steadily declined after the third treatment day. Expression of mRNA for P450SCC and 3 beta-HSD was markedly stimulated (P < 0.05) by hCG treatment early in the luteal phase. However, 3 beta-HSD message levels in corpora lutea from animals treated with hCG on days 10-16 were not different from those of day-16 control corpora lutea, whereas P450SCC mRNA was only minimally stimulated. There was a dramatic (P < 0.05) increase in mRNA levels for the aromatase enzyme and low density lipoprotein receptor in animals given hCG in both the early and the late luteal phase. In conclusion, there appears to be a differential responsiveness of the primate corpus luteum to hCG stimulation dependent upon luteal age. The loss in responsiveness to hCG in terms of maintenance of mRNA levels is reflective of the inability of the late luteal phase corpus luteum for continued progesterone biosynthesis in the face of heightened luteotropic stimulation.
在非受孕周期中,灵长类动物黄体的绝对类固醇生成能力,如通过孕酮生物合成酶细胞色素P450胆固醇侧链裂解酶(P450SCC)和3β-羟基类固醇脱氢酶(3β-HSD)的信使核糖核酸(mRNA)表达所反映的那样,会逐渐下降直至黄体退化。尽管黄体细胞功能逐渐丧失,但植入的胚泡分泌的绒毛膜促性腺激素(CG)能够延长黄体的功能寿命。本研究的目的是探讨灵长类动物黄体老化与CG阻止黄体细胞功能下降的细胞机制之间的关系。在第5天或第10天开始,对食蟹猴进行为期7天的递增剂量人绒毛膜促性腺激素(hCG)肌肉注射治疗,在黄体期第11天或第16天获取黄体。也从处于黄体期第5、10、11和16天的对照动物获取黄体。在整个治疗期间,hCG治疗显著(P<0.05)提高了血清孕酮和雌二醇水平;然而,在黄体期后期(第10 - 16天)接受hCG治疗的动物,其孕酮分泌在第三次治疗后稳步下降。hCG在黄体期早期治疗显著刺激(P<0.05)了P450SCC和3β-HSD的mRNA表达。然而,在第10 - 16天接受hCG治疗的动物的黄体中,3β-HSD的信使水平与第16天对照黄体的信使水平没有差异,而P450SCC的mRNA仅受到最小程度的刺激。在黄体期早期和晚期接受hCG治疗的动物中,芳香化酶和低密度脂蛋白受体的mRNA水平都有显著(P<0.05)升高。总之,灵长类动物黄体对hCG刺激的反应性似乎因黄体年龄而异。就维持mRNA水平而言,对hCG反应性的丧失反映了黄体期后期黄体在黄体生成素刺激增强的情况下无法继续进行孕酮生物合成。